Global Lacosamide Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Lacosamide Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ('complementary therapy') to treat focal seizures (seizures that start in one area of the brain).
This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lacosamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lacosamide Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories and Alembic Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lacosamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales, revenue and global market share of Lacosamide Tablets from 2018 to 2023.
Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lacosamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ('complementary therapy') to treat focal seizures (seizures that start in one area of the brain).
This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lacosamide Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lacosamide Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories and Alembic Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lacosamide Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 50 mg/tablet
- 100 mg/tablet
- 150 mg/tablet
- 200 mg/tablet
- Adults
- Children
- UCB
- Aesica Pharmaceuticals GmbH
- Teva
- MSN Laboratories
- Alembic Pharma
- Glenmark
- Accord Healthcare
- Mylan
- Sun PharmaApotex
- Jiangxi Qingfeng Pharmaceutical
- Beijing Sihuan Pharmaceutical
- Buchang Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales, revenue and global market share of Lacosamide Tablets from 2018 to 2023.
Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lacosamide Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Lacosamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg/tablet
1.3.3 100 mg/tablet
1.3.4 150 mg/tablet
1.3.5 200 mg/tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Lacosamide Tablets Market Size & Forecast
1.5.1 Global Lacosamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lacosamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Lacosamide Tablets Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Tablets Product and Services
2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 UCB Recent Developments/Updates
2.2 Aesica Pharmaceuticals GmbH
2.2.1 Aesica Pharmaceuticals GmbH Details
2.2.2 Aesica Pharmaceuticals GmbH Major Business
2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Lacosamide Tablets Product and Services
2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alembic Pharma Recent Developments/Updates
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Tablets Product and Services
2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Recent Developments/Updates
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Accord Healthcare Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Lacosamide Tablets Product and Services
2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 Sun PharmaApotex
2.9.1 Sun PharmaApotex Details
2.9.2 Sun PharmaApotex Major Business
2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun PharmaApotex Recent Developments/Updates
2.10 Jiangxi Qingfeng Pharmaceutical
2.10.1 Jiangxi Qingfeng Pharmaceutical Details
2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
2.11 Beijing Sihuan Pharmaceutical
2.11.1 Beijing Sihuan Pharmaceutical Details
2.11.2 Beijing Sihuan Pharmaceutical Major Business
2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
2.12 Buchang Pharmaceutical
2.12.1 Buchang Pharmaceutical Details
2.12.2 Buchang Pharmaceutical Major Business
2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Buchang Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LACOSAMIDE TABLETS BY MANUFACTURER
3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lacosamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Lacosamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Lacosamide Tablets Manufacturer Market Share in 2022
3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Lacosamide Tablets Market: Region Footprint
3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Lacosamide Tablets Market Size by Region
4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Lacosamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Lacosamide Tablets Average Price by Region (2018-2029)
4.2 North America Lacosamide Tablets Consumption Value (2018-2029)
4.3 Europe Lacosamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029)
4.5 South America Lacosamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Lacosamide Tablets Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Lacosamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Lacosamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Lacosamide Tablets Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Lacosamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Lacosamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Lacosamide Tablets Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Lacosamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Lacosamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Lacosamide Tablets Market Size by Country
7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Lacosamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Lacosamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Lacosamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Lacosamide Tablets Market Size by Country
8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Lacosamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Lacosamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Lacosamide Tablets Market Size by Country
10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Lacosamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Lacosamide Tablets Market Drivers
12.2 Lacosamide Tablets Market Restraints
12.3 Lacosamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lacosamide Tablets
13.3 Lacosamide Tablets Production Process
13.4 Lacosamide Tablets Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lacosamide Tablets Typical Distributors
14.3 Lacosamide Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Lacosamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50 mg/tablet
1.3.3 100 mg/tablet
1.3.4 150 mg/tablet
1.3.5 200 mg/tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Lacosamide Tablets Market Size & Forecast
1.5.1 Global Lacosamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Lacosamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Lacosamide Tablets Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 UCB
2.1.1 UCB Details
2.1.2 UCB Major Business
2.1.3 UCB Lacosamide Tablets Product and Services
2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 UCB Recent Developments/Updates
2.2 Aesica Pharmaceuticals GmbH
2.2.1 Aesica Pharmaceuticals GmbH Details
2.2.2 Aesica Pharmaceuticals GmbH Major Business
2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Lacosamide Tablets Product and Services
2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Alembic Pharma
2.5.1 Alembic Pharma Details
2.5.2 Alembic Pharma Major Business
2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alembic Pharma Recent Developments/Updates
2.6 Glenmark
2.6.1 Glenmark Details
2.6.2 Glenmark Major Business
2.6.3 Glenmark Lacosamide Tablets Product and Services
2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Glenmark Recent Developments/Updates
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Accord Healthcare Recent Developments/Updates
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Lacosamide Tablets Product and Services
2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mylan Recent Developments/Updates
2.9 Sun PharmaApotex
2.9.1 Sun PharmaApotex Details
2.9.2 Sun PharmaApotex Major Business
2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sun PharmaApotex Recent Developments/Updates
2.10 Jiangxi Qingfeng Pharmaceutical
2.10.1 Jiangxi Qingfeng Pharmaceutical Details
2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
2.11 Beijing Sihuan Pharmaceutical
2.11.1 Beijing Sihuan Pharmaceutical Details
2.11.2 Beijing Sihuan Pharmaceutical Major Business
2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
2.12 Buchang Pharmaceutical
2.12.1 Buchang Pharmaceutical Details
2.12.2 Buchang Pharmaceutical Major Business
2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Buchang Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: LACOSAMIDE TABLETS BY MANUFACTURER
3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Lacosamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Lacosamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Lacosamide Tablets Manufacturer Market Share in 2022
3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Lacosamide Tablets Market: Region Footprint
3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Lacosamide Tablets Market Size by Region
4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Lacosamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Lacosamide Tablets Average Price by Region (2018-2029)
4.2 North America Lacosamide Tablets Consumption Value (2018-2029)
4.3 Europe Lacosamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029)
4.5 South America Lacosamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Lacosamide Tablets Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Lacosamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Lacosamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Lacosamide Tablets Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Lacosamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Lacosamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Lacosamide Tablets Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Lacosamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Lacosamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Lacosamide Tablets Market Size by Country
7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Lacosamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Lacosamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Lacosamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Lacosamide Tablets Market Size by Country
8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Lacosamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Lacosamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Lacosamide Tablets Market Size by Country
10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Lacosamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Lacosamide Tablets Market Drivers
12.2 Lacosamide Tablets Market Restraints
12.3 Lacosamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lacosamide Tablets
13.3 Lacosamide Tablets Production Process
13.4 Lacosamide Tablets Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lacosamide Tablets Typical Distributors
14.3 Lacosamide Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. UCB Basic Information, Manufacturing Base and Competitors
Table 4. UCB Major Business
Table 5. UCB Lacosamide Tablets Product and Services
Table 6. UCB Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. UCB Recent Developments/Updates
Table 8. Aesica Pharmaceuticals GmbH Basic Information, Manufacturing Base and Competitors
Table 9. Aesica Pharmaceuticals GmbH Major Business
Table 10. Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
Table 11. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Aesica Pharmaceuticals GmbH Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Lacosamide Tablets Product and Services
Table 16. Teva Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. MSN Laboratories Major Business
Table 20. MSN Laboratories Lacosamide Tablets Product and Services
Table 21. MSN Laboratories Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MSN Laboratories Recent Developments/Updates
Table 23. Alembic Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharma Major Business
Table 25. Alembic Pharma Lacosamide Tablets Product and Services
Table 26. Alembic Pharma Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Alembic Pharma Recent Developments/Updates
Table 28. Glenmark Basic Information, Manufacturing Base and Competitors
Table 29. Glenmark Major Business
Table 30. Glenmark Lacosamide Tablets Product and Services
Table 31. Glenmark Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Glenmark Recent Developments/Updates
Table 33. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Accord Healthcare Major Business
Table 35. Accord Healthcare Lacosamide Tablets Product and Services
Table 36. Accord Healthcare Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Accord Healthcare Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Lacosamide Tablets Product and Services
Table 41. Mylan Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mylan Recent Developments/Updates
Table 43. Sun PharmaApotex Basic Information, Manufacturing Base and Competitors
Table 44. Sun PharmaApotex Major Business
Table 45. Sun PharmaApotex Lacosamide Tablets Product and Services
Table 46. Sun PharmaApotex Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun PharmaApotex Recent Developments/Updates
Table 48. Jiangxi Qingfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Jiangxi Qingfeng Pharmaceutical Major Business
Table 50. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
Table 51. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 53. Beijing Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Sihuan Pharmaceutical Major Business
Table 55. Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
Table 56. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 58. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Buchang Pharmaceutical Major Business
Table 60. Buchang Pharmaceutical Lacosamide Tablets Product and Services
Table 61. Buchang Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Buchang Pharmaceutical Recent Developments/Updates
Table 63. Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Lacosamide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Lacosamide Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Lacosamide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Lacosamide Tablets Production Site of Key Manufacturer
Table 68. Lacosamide Tablets Market: Company Product Type Footprint
Table 69. Lacosamide Tablets Market: Company Product Application Footprint
Table 70. Lacosamide Tablets New Market Entrants and Barriers to Market Entry
Table 71. Lacosamide Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Lacosamide Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Lacosamide Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Lacosamide Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Lacosamide Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Lacosamide Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Lacosamide Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Lacosamide Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Lacosamide Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Lacosamide Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Lacosamide Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Lacosamide Tablets Raw Material
Table 131. Key Manufacturers of Lacosamide Tablets Raw Materials
Table 132. Lacosamide Tablets Typical Distributors
Table 133. Lacosamide Tablets Typical Customers
Table 1. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. UCB Basic Information, Manufacturing Base and Competitors
Table 4. UCB Major Business
Table 5. UCB Lacosamide Tablets Product and Services
Table 6. UCB Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. UCB Recent Developments/Updates
Table 8. Aesica Pharmaceuticals GmbH Basic Information, Manufacturing Base and Competitors
Table 9. Aesica Pharmaceuticals GmbH Major Business
Table 10. Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
Table 11. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Aesica Pharmaceuticals GmbH Recent Developments/Updates
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Major Business
Table 15. Teva Lacosamide Tablets Product and Services
Table 16. Teva Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Recent Developments/Updates
Table 18. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. MSN Laboratories Major Business
Table 20. MSN Laboratories Lacosamide Tablets Product and Services
Table 21. MSN Laboratories Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MSN Laboratories Recent Developments/Updates
Table 23. Alembic Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Alembic Pharma Major Business
Table 25. Alembic Pharma Lacosamide Tablets Product and Services
Table 26. Alembic Pharma Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Alembic Pharma Recent Developments/Updates
Table 28. Glenmark Basic Information, Manufacturing Base and Competitors
Table 29. Glenmark Major Business
Table 30. Glenmark Lacosamide Tablets Product and Services
Table 31. Glenmark Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Glenmark Recent Developments/Updates
Table 33. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Accord Healthcare Major Business
Table 35. Accord Healthcare Lacosamide Tablets Product and Services
Table 36. Accord Healthcare Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Accord Healthcare Recent Developments/Updates
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Major Business
Table 40. Mylan Lacosamide Tablets Product and Services
Table 41. Mylan Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mylan Recent Developments/Updates
Table 43. Sun PharmaApotex Basic Information, Manufacturing Base and Competitors
Table 44. Sun PharmaApotex Major Business
Table 45. Sun PharmaApotex Lacosamide Tablets Product and Services
Table 46. Sun PharmaApotex Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sun PharmaApotex Recent Developments/Updates
Table 48. Jiangxi Qingfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Jiangxi Qingfeng Pharmaceutical Major Business
Table 50. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
Table 51. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
Table 53. Beijing Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Sihuan Pharmaceutical Major Business
Table 55. Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
Table 56. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Sihuan Pharmaceutical Recent Developments/Updates
Table 58. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Buchang Pharmaceutical Major Business
Table 60. Buchang Pharmaceutical Lacosamide Tablets Product and Services
Table 61. Buchang Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Buchang Pharmaceutical Recent Developments/Updates
Table 63. Global Lacosamide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Lacosamide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Lacosamide Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Lacosamide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Lacosamide Tablets Production Site of Key Manufacturer
Table 68. Lacosamide Tablets Market: Company Product Type Footprint
Table 69. Lacosamide Tablets Market: Company Product Application Footprint
Table 70. Lacosamide Tablets New Market Entrants and Barriers to Market Entry
Table 71. Lacosamide Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Lacosamide Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Lacosamide Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Lacosamide Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Lacosamide Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Lacosamide Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Lacosamide Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Lacosamide Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Lacosamide Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Lacosamide Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Lacosamide Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Lacosamide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Lacosamide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Lacosamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Lacosamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Lacosamide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Lacosamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Lacosamide Tablets Raw Material
Table 131. Key Manufacturers of Lacosamide Tablets Raw Materials
Table 132. Lacosamide Tablets Typical Distributors
Table 133. Lacosamide Tablets Typical Customers
LIST OF FIGURES
Figure 1. Lacosamide Tablets Picture
Figure 2. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lacosamide Tablets Consumption Value Market Share by Type in 2022
Figure 4. 50 mg/tablet Examples
Figure 5. 100 mg/tablet Examples
Figure 6. 150 mg/tablet Examples
Figure 7. 200 mg/tablet Examples
Figure 8. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Lacosamide Tablets Consumption Value Market Share by Application in 2022
Figure 10. Adults Examples
Figure 11. Children Examples
Figure 12. Global Lacosamide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Lacosamide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Lacosamide Tablets Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Lacosamide Tablets Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Lacosamide Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Lacosamide Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Lacosamide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Lacosamide Tablets Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Lacosamide Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Lacosamide Tablets Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Lacosamide Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 54. China Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Lacosamide Tablets Market Drivers
Figure 75. Lacosamide Tablets Market Restraints
Figure 76. Lacosamide Tablets Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Lacosamide Tablets in 2022
Figure 79. Manufacturing Process Analysis of Lacosamide Tablets
Figure 80. Lacosamide Tablets Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Lacosamide Tablets Picture
Figure 2. Global Lacosamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Lacosamide Tablets Consumption Value Market Share by Type in 2022
Figure 4. 50 mg/tablet Examples
Figure 5. 100 mg/tablet Examples
Figure 6. 150 mg/tablet Examples
Figure 7. 200 mg/tablet Examples
Figure 8. Global Lacosamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Lacosamide Tablets Consumption Value Market Share by Application in 2022
Figure 10. Adults Examples
Figure 11. Children Examples
Figure 12. Global Lacosamide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Lacosamide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Lacosamide Tablets Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Lacosamide Tablets Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Lacosamide Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Lacosamide Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Lacosamide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Lacosamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Lacosamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Lacosamide Tablets Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Lacosamide Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Lacosamide Tablets Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Lacosamide Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 54. China Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Lacosamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Lacosamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Lacosamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Lacosamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Lacosamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Lacosamide Tablets Market Drivers
Figure 75. Lacosamide Tablets Market Restraints
Figure 76. Lacosamide Tablets Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Lacosamide Tablets in 2022
Figure 79. Manufacturing Process Analysis of Lacosamide Tablets
Figure 80. Lacosamide Tablets Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
